- Home
- VALN vs SITC Comparison
VALN vs SITC Comparison
Compare VALN & SITC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VALN
- SITC
- Stock Information
- Founded
- VALN 2012
- SITC 1965
- Country
- VALN France
- SITC United States
- Employees
- VALN N/A
- SITC N/A
- Industry
- VALN Biotechnology: Biological Products (No Diagnostic Substances)
- SITC Real Estate Investment Trusts
- Sector
- VALN Health Care
- SITC Real Estate
- Exchange
- VALN Nasdaq
- SITC Nasdaq
- Market Cap
- VALN 542.5M
- SITC 603.1M
- IPO Year
- VALN 2021
- SITC 1993
- Fundamental
- Price
- VALN $6.00
- SITC $11.49
- Analyst Decision
- VALN Strong Buy
- SITC Hold
- Analyst Count
- VALN 3
- SITC 8
- Target Price
- VALN $15.33
- SITC $35.25
- AVG Volume (30 Days)
- VALN 14.6K
- SITC 1.5M
- Earning Date
- VALN 08-12-2025
- SITC 07-29-2025
- Dividend Yield
- VALN N/A
- SITC 13.09%
- EPS Growth
- VALN N/A
- SITC 151.17
- EPS
- VALN N/A
- SITC 10.32
- Revenue
- VALN $201,099,222.00
- SITC $227,525,000.00
- Revenue This Year
- VALN $18.74
- SITC N/A
- Revenue Next Year
- VALN $29.26
- SITC $12.69
- P/E Ratio
- VALN N/A
- SITC $1.12
- Revenue Growth
- VALN 21.64
- SITC N/A
- 52 Week Low
- VALN $3.62
- SITC $10.46
- 52 Week High
- VALN $8.66
- SITC $18.15
- Technical
- Relative Strength Index (RSI)
- VALN 52.41
- SITC 43.26
- Support Level
- VALN $5.57
- SITC $11.34
- Resistance Level
- VALN $6.19
- SITC $11.65
- Average True Range (ATR)
- VALN 0.29
- SITC 0.29
- MACD
- VALN 0.05
- SITC -0.08
- Stochastic Oscillator
- VALN 65.60
- SITC 11.83
About VALN Valneva SE
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.
About SITC SITE Centers Corp.
SITE Centers Corp is a self-administered and self-managed REIT that operates as a fully integrated real estate company. The company is engaged in the business of owning, leasing, acquiring, redeveloping, developing and managing shopping centers.